Related Experiment Videos

[Congenital type I antithrombin III deficiency with serious complications in a 7-year-old girl]

Orvosi Hetilap
|March 19, 1989
PubMed

Insights

This case report details a child with recurrent thromboembolism due to antithrombin III deficiency. Early diagnosis and Syncumar therapy successfully managed the condition, preventing further complications.

Area of Science:

  • Pediatrics
  • Hematology
  • Genetics

Background:

  • A child presented with neurological symptoms including ataxia, focal convulsions, and hemiparesis.
  • Initial treatment with anticonvulsants resolved seizures but not hemiparesis.

Observation:

  • Progressive venous thrombosis in lower limbs developed at age six and a half.
  • Phlebography revealed iliac vein thrombosis, femoral vein stenosis, and abdominal venous collaterals.
  • Coeliacography showed splenomegaly and portal vein varicosity.
  • Arterial thrombosis of the arteria dorsalis pedis led to toe gangrene.

Findings:

  • Hemostasis examination indicated hypercoagulability secondary to antithrombin III deficiency.
  • Reduced antithrombin III activity was also noted in the child's mother and two sisters.
  • This genetic deficiency was identified as the underlying cause of recurrent thromboembolism.

Implications:

  • Highlights the importance of investigating hypercoagulability in pediatric patients with unexplained thrombotic events.
  • Demonstrates the efficacy of anticoagulation therapy, specifically Syncumar, in managing antithrombin III deficiency-related thromboembolism.
  • Suggests genetic counseling and screening for family members affected by antithrombin III deficiency.

Related Concept Videos